Target intelligence / Profile preview

SET nuclear oncogene pseudogene 6 (SETP6)

Target: SETP6
Molecular classification: Other

Overview

SET nuclear oncogene pseudogene 6 (SETP6) is a processed human pseudogene annotated in genomic databases. As a pseudogene, it does not encode a functional protein and lacks known protein-coding capacity[4][7][8]. There is no evidence for a direct biological role or pathological association for SETP6 in human disease. Unlike some pseudogenes which may act as regulatory non-coding RNAs, there are no current reports supporting such a function for this locus. Therefore, SETP6 is not considered a druggable therapeutic target and has no established relevance as a biomarker or pharmacological entity[4][7][8].

Other names: SETP6SET pseudogene 6SET nuclear oncogene pseudogene 6

Beyond the preview

Go deeper on SET nuclear oncogene pseudogene 6 (SETP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SET nuclear oncogene pseudogene 6 (SETP6).

Explore the full profile